×
About 20,518 results

ALLMedicine™ Menopause Center

Research & Reviews  5,978 results

Plasma proteomic signature of cellular senescence and markers of biological aging among...
https://doi.org/10.1089/rej.2022.0024
Rejuvenation Research; Shin JW, Lee E et. al.

May 19th, 2022 - We aimed to investigate the association of circulatory senescence-associated secretory phenotypes (SASP) produced by senescent cells with chronological and menopausal age in women aged 45 years or more. The proteomic profiles for 32 SASP factors o...

A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple...
https://clinicaltrials.gov/ct2/show/NCT05381142

May 19th, 2022 - Researchers are looking for a better way to treat men and women with vasomotor symptoms, a condition of having hot flashes caused by hormonal changes. In women, these hormonal changes happen in the time around their menopause, the last period (men...

Menopause: Guidance for Practice.
https://doi.org/10.1177/20533691221097039
Post Reproductive Health;

May 18th, 2022 - Menopause: Guidance for Practice.|2022||

Association of Chronological Age, Subjective Age and Bio-functional Age With Serum Anti-müllerian Hormone
https://clinicaltrials.gov/ct2/show/NCT05297058

May 18th, 2022 - As life expectancy is increasing and has significant effects on health, economy and other aspects, the need for an Active and Healthy ageing (AHA) strategy becomes more important. Although ageing is often defined by chronological age (CA), it is s...

Early signs of sleep-disordered breathing in healthy women predict carotid intima-media...
https://doi.org/10.1016/j.sleep.2022.04.009
Sleep Medicine; Kalleinen N, Saaresranta T et. al.

May 17th, 2022 - Cardiovascular disease (CVD) is the leading cause of death in women. The risk of CVD increases in women after menopause. The aim was to study how sleep parameters and cardiovascular risk factors in 46-year-old women predict future carotid intima-m...

see more →

Guidelines  51 results

Guideline No. 422g: Menopause and Osteoporosis.
https://doi.org/10.1016/j.jogc.2021.09.013
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Khan AA, Alrob HA et. al.

May 17th, 2022 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...

Menopause modulates the circulating metabolome: evidence from a prospective cohort study
https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwac060/6580397?login=false
European Journal of Preventive Cardiology; Karppinen JE, .

May 12th, 2022 - We studied the changes in the circulating metabolome and their relation to the menopausal hormonal shift in 17β-oestradiol and follicle-stimulating hormone levels among women transitioning from perimenopause to early postmenopause.

Guideline No. 425a: Cannabis Use Throughout Women's Lifespans - Part 1: Fertility, Cont...
https://doi.org/10.1016/j.jogc.2022.01.012
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Robert M, Graves LE et. al.

Apr 12th, 2022 - To provide health care providers with the best evidence on cannabis use with respect to women's health. Areas of focus include general patterns of cannabis use as well as safety of use; care for women who use cannabis; stigma; screening, brief int...

Directive clinique no 425a : Le cannabis aux différentes périodes de la vie des femmes ...
https://doi.org/10.1016/j.jogc.2022.02.013
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Robert M, Graves LE et. al.

Apr 12th, 2022 - Fournir aux fournisseurs de soins de santé les meilleures données probantes sur l'utilisation de cannabis et la santé des femmes. Les domaines d'intérêt sont : les profils généraux d'utilisation du cannabis ainsi que la sécurité de la consommation...

Evaluation and Treatment in Urology for Nocturia Caused by Nonurological Mechanisms: Gu...
https://doi.org/10.1016/j.euf.2022.01.007
European Urology Focus; Smith M, Dawson S et. al.

Feb 2nd, 2022 - Patients with nocturia are commonly referred to urology clinics, including many for whom a nonurological medical condition is responsible for their symptoms. The PLanning Appropriate Nocturia Evaluation and Treatment (PLANET) study was established...

see more →

Drugs  267 results see all →

Clinicaltrials.gov  261 results

A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple...
https://clinicaltrials.gov/ct2/show/NCT05381142

May 19th, 2022 - Researchers are looking for a better way to treat men and women with vasomotor symptoms, a condition of having hot flashes caused by hormonal changes. In women, these hormonal changes happen in the time around their menopause, the last period (men...

Association of Chronological Age, Subjective Age and Bio-functional Age With Serum Anti-müllerian Hormone
https://clinicaltrials.gov/ct2/show/NCT05297058

May 18th, 2022 - As life expectancy is increasing and has significant effects on health, economy and other aspects, the need for an Active and Healthy ageing (AHA) strategy becomes more important. Although ageing is often defined by chronological age (CA), it is s...

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have ...
https://clinicaltrials.gov/ct2/show/NCT05042362

May 17th, 2022 - Researchers are looking for a better way to treat women who have hot flashes after women have been through the menopause. Hot flashes are caused by the hormonal changes that happen when a woman's body has been through the menopause. Menopause is w...

A Survey About Trade-offs When Choosing Menopause Treatments
https://clinicaltrials.gov/ct2/show/NCT05300568

May 13th, 2022 - This study is an online survey of women in menopause with moderate to severe hot flashes. Menopause, a normal part of life, is the time after a woman's last period. Hot flashes often occur during menopause. They can disrupt a woman's daily life. T...

Menopause modulates the circulating metabolome: evidence from a prospective cohort study
https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwac060/6580397?login=false
European Journal of Preventive Cardiology; Karppinen JE, .

May 12th, 2022 - We studied the changes in the circulating metabolome and their relation to the menopausal hormonal shift in 17β-oestradiol and follicle-stimulating hormone levels among women transitioning from perimenopause to early postmenopause.

see more →

News  1,567 results

Hormones Account for 10% of Lipid Changes After Menopause
https://www.medscape.com/viewarticle/974220

May 18th, 2022 - The transition from perimenopause to menopause is accompanied by a proatherogenic shift in lipids and other circulating metabolites that potentially predispose women to cardiovascular disease (CVD). Now, for the first time, a new prospective cohor...

Menopause modulates the circulating metabolome: evidence from a prospective cohort study
https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwac060/6580397?login=false
European Journal of Preventive Cardiology; Karppinen JE, .

May 12th, 2022 - We studied the changes in the circulating metabolome and their relation to the menopausal hormonal shift in 17β-oestradiol and follicle-stimulating hormone levels among women transitioning from perimenopause to early postmenopause.

Tau Moderated by Menopause; CTE Risk Underestimated; When Is a Single Study Enough?
https://www.medpagetoday.com/neurology/generalneurology/98523

May 3rd, 2022 - Menopause status moderated sex differences in tau burden, with a divergence in tauopathy between the sexes apparent 20 years earlier than previously reported. (Annals of Neurology) Plasma p-tau was a less consistent marker of brain amyloidosis in ...

Hormones after cancer: Are they safe?
https://www.mdedge.com/obgyn/article/253917/gynecologic-cancer/hormones-after-cancer-are-they-safe
Emma C. Rossi, MD

Apr 20th, 2022 - The impact of a gynecologic cancer diagnosis reaches beyond the obvious side effects of surgery, chemotherapy, and radiation. Many of our patients experience the quality-of-life–limiting side effects of abrupt hormone withdrawal as a consequence o.

SERMs revisited: Can they improve menopausal care?
https://www.mdedge.com/obgyn/article/253626/menopause/serms-revisited-can-they-improve-menopausal-care
Steven R. Goldstein, MD, NCMP, CCD

Apr 8th, 2022 - Selective estrogen receptor modulators (SERMs) are unique synthetic compounds that bind to the estrogen receptor and initiate either estrogenic agonistic or antagonistic activity, depending on the confirmational change they produce on binding to t.

see more →

Patient Education  83 results see all →